Plague has killed millions of people during the past 25 centuries, and the disease reappeared in several countries during the 1990s. Consequently, plague was categorized as a re-emerging disease. Human plague outbreaks continue to be reported, including an outbreak of pneumonic plague in Madagascar in 20...
Tacconelli, E;
Mazzaferri, F;
Smet, A.M. de;
Bragantini, D;
Eggimann, P;
Huttner, B. D;
Kuijper, E. J;
Lucet, J. C;
Mutters, N. T;
Sanguinetti, M;
Schwaber, M. J;
Souli, M;
Torre-Cisneros, J;
Price, J. R;
Rodríguez-Bano, J.
The aim of these guidelines is to provide recommendations for decolonizing regimens targeting
multidrug-resistant Gram-negative bacteria (MDR-GNB) carriers in all settings.
Methods: These evidence-based guidelines were produced after a systematic review of published studies
on decolonization intervention...
Infections bactériennes à Gram négatif/diagnostic,
Infections bactériennes à Gram négatif/prévention et contrôle,
Infections bactériennes à Gram négatif/transmission,
Politique Éclairée par la Preuve,
Infections à Enterobacteriaceae/prévention et contrôle,
Infections à Enterobacteriaceae/transmission,
Infections à Enterobacteriaceae/diagnostic,
Résistance aux céphalosporines/effets des médicaments et des substances chimiques,
Céphalosporines/usage thérapeutique,
Aminosides/usage thérapeutique,
Fluoroquinolones/usage thérapeutique,
Transplantation de microbiote fécal/instrumentation
Wedzicha, JA;
Calverley, PMA;
Albert, RK;
Anzueto, A;
Criner, GJ;
Hurst, JR;
Miravitlles, M;
Papi, A;
Rabe, KF;
Rigau, D;
Sliwinski, P;
Tonia, T;
Vestbo, J;
Wilson, KC;
Krishnan, JA.
This document provides clinical recommendations for the prevention of chronic obstructive pulmonary disease (COPD) exacerbations. It represents a collaborative effort between the European Respiratory Society and the American Thoracic Society.Comprehensive evidence syntheses were performed to summarise al...
Agonistes des récepteurs béta-2 adrénergiques/usage thérapeutique,
Aminopyridines/usage thérapeutique,
Benzamides/usage thérapeutique,
Cyclopropanes/usage thérapeutique,
Fluoroquinolones/usage thérapeutique,
Macrolides/usage thérapeutique,
Antagonistes muscariniques/usage thérapeutique,
Inhibiteurs de la phosphodiestérase-4/usage thérapeutique,
Évolution de la maladie,
Broncho-pneumopathie chronique obstructive,
Broncho-pneumopathie chronique obstructive/traitement médicamenteux,
Broncho-pneumopathie chronique obstructive/physiopathologie,
Prévention secondaire/normes,
Agonistes des récepteurs béta-2 adrénergiques,
Aminopyridines,
Benzamides,
Cyclopropanes,
Fluoroquinolones,
Macrolides,
Antagonistes muscariniques,
Inhibiteurs de la phosphodiestérase-4
The present guideline update aims to use the best available evidence on the treatment of drug-susceptible TB, as well as on interventions to ensure adequate patient care and support, in order to inform policy decisions made in these technical areas by national TB control programme managers, national poli...
This document provides a summary of the evidence and recommendations for the use of SL-LPA for the detection of mutations associated with resistance to fluoroquinolones and SLID in patients with RR-TB and/or MDR-TB. The objectives of this policy guidance are to assess and compare the diagnostic accuracy ...
Tuberculose multirésistante/diagnostic,
Antibiotiques antituberculeux/pharmacologie,
Techniques de sonde moléculaire,
Tests de sensibilité microbienne,
Fluoroquinolones/usage thérapeutique,
Résistance bactérienne aux médicaments/génétique,
Génotype,
Mutation,
Tuberculose multirésistante/génétique,
Mycobacterium tuberculosis/effets des médicaments et des substances chimiques,
Mycobacterium tuberculosis/génétique
Community-acquired pneumonia is diagnosed by clinical features (e.g., cough, fever, pleuritic chest pain) and by lung
imaging, usually an infiltrate seen on chest radiography. Initial evaluation should determine the need for hospitalization versus outpatient management using validated mortality or severi...
Pneumopathie infectieuse/imagerie diagnostique,
Pneumopathie infectieuse/thérapie,
Maladies de l'appareil respiratoire/diagnostic,
Soins ambulatoires/organisation et administration,
Hémoculture/instrumentation,
Macrolides/usage thérapeutique,
Doxycycline/usage thérapeutique,
Antibactériens/usage thérapeutique,
Fluoroquinolones/usage thérapeutique,
Unités de soins intensifs,
Pneumonie associée aux soins/prévention et contrôle
